Essen Coronary Artery Disease Registry

The ECAD registry is a registry of patients undergoing coronary angiography at the West German Heart and Vascular Center. The registry anticipates to determine predictors of patient outcome after coronary angiography.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Essen

Essen, North Rhine-Westphalia, 45147, Germany

Location status: Recruiting

Location contact

Amir A Mahabadi, MD

CONTACT

[email protected]

+49201723 ext. 84822

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing invasive coronary angiography at the West German Heart and Vascular Center

Exclusion criteria

None

Treatment and study plan

Primary outcomes

All-cause mortality

Time frame: through study completion, an average of 3 year

Mortality of any cause

Study contacts

Contact information is provided by the study sponsor or research team.

Amir A Mahabadi, MD

CONTACT

[email protected]

+49 201 723 ext. 84822

Matthias Totzeck, MD

CONTACT

[email protected]

+49 201 723 ext. 84805

Sponsors and collaborators

Lead sponsor

University Hospital, Essen

Other

Registry information

Acronym: ECAD registry

Important dates

Study start: 2019
Primary completion: 2026
Study completion: 2027
First posted: Dec 12, 2019
Registry last updated: Dec 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting